Global Ophthalmic Viscoelastic Devices Market
Ophthalmic Viscoelastic Devices Market

Report ID: SQMIG35A3046

sales@skyquestt.com
USA +1 351-333-4748

Ophthalmic Viscoelastic Devices Market Size, Share, and Growth Analysis

Global Ophthalmic Viscoelastic Devices Market

Ophthalmic Viscoelastic Devices Market By Product Type (Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic), By Application (Cataract, Glaucoma, Corneal Transplant, Vitreoretinal Surgery), By End User (Hospitals, Ophthalmic Clinics, Others), By Region-Industry Forecast 2026-2033


Report ID: SQMIG35A3046 | Region: Global | Published Date: June, 2025
Pages: 197 |Tables: 78 |Figures: 69

Format - word format excel data power point presentation

Ophthalmic Viscoelastic Devices Market Insights

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 11.72 Billion in 2024 and is poised to grow from USD 13.08 Billion in 2025 to USD 31.47 Billion by 2033, growing at a CAGR of 11.6% during the forecast period (2026–2033).

Increasing demand for minimally invasive eye surgeries and advancements in viscoelastic material formulations are further propelling market expansion. Several eye-related diseases, including cataract, glaucoma, corneal transplant, age-related macular degeneration, and diabetic retinopathy, require the use of ophthalmic viscoelastic devices during surgery. These ophthalmic visco-surgical devices are critical for providing proper treatment to patients in order to avoid further vision damage or loss of vision.

The ophthalmic viscoelastic devices market is witnessing steady growth driven by the rising prevalence of eye disorders such as cataracts, glaucoma, and age-related macular degeneration.

The increasing number of ophthalmic surgeries across the globe is one of the key factors driving the market growth. OVDs are widely used to maintain, preserve space, displace, stabilize, and protect tissues. In line with this, improving access to ophthalmic care facilities and rising awareness about ocular disorders are acting as another growth-inducing factor. Moreover, the widespread utilization of viscoadaptive ophthalmic viscosurgical devices, due to the increasing number of complex ocular surgical cases and its biphasic benefit of eliminating the need for two syringes is propelling the market growth. In corneal transplantation surgery (keratoplasty), the damaged cornea is replaced by donated corneal tissue.

How Is AI Transforming the Ophthalmic Viscoelastic Devices Market?

Artificial intelligence (AI) affects the ophthalmic viscoelastic devices market by increasing surgical accuracy and patient results. AI-operated depiction and diagnostic tools enable ophthalmologists to create better planning and perform complex eye surgery, which allows more accurate use of viscolatic tools. In 2024, for example, a leading medical technology company introduced an AI capable surgical guidance system, which helps surgeons during cataract operations by providing real-time reaction and optimal suggestions for viscolastic unit. This innovation increases surgical accuracy and reduces the time of the process, showing how AI-powered solutions become integrated with eye-related surgery.

Market snapshot - 2026-2033

Global Market Size

USD 10.5 billion

Largest Segment

Cohesive Ophthalmic Viscoelastic

Fastest Growth

Dispersive Ophthalmic Viscoelastic

Growth Rate

11.6% CAGR

Global Ophthalmic Viscoelastic Devices Market 2026-2033 ($ Bn)
Country Share for North America Region 2025 (%)

To get more insights on this market click here to Request a Free Sample Report

Ophthalmic Viscoelastic Devices Market Segments Analysis

The ophthalmic viscoelastic devices market is segmented into product type, application, end user and region. Based on product type, the market is segmented into cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Based on application, the market is segmented into cataract, glaucoma, corneal transplant and vitreoretinal surgery. Based on end user, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Which Factors Make Cohesive Ophthalmic Viscoelastic Devices Preferred in Common Surgeries?

As per the global ophthalmic viscoelastic devices market forecast, the cohesive ophthalmic viscoelastic segment holds dominance in the market primarily because of its unique physical properties that make it highly efficient during common ophthalmic surgeries. Cohesive viscoelastic tend to stick together in a single mass, which allows surgeons to maintain a stable surgical space within the eye. This characteristic enables easy injection and, importantly, quick and complete removal at the end of the procedure. The efficiency and predictability of cohesive agents minimize intraoperative complications and postoperative inflammation, which contributes to their widespread use and market dominance.

As per the global ophthalmic viscoelastic devices market analysis, the dispersive ophthalmic viscoelastic segment is witnessing strong growth driven by its ability to adhere to and protect sensitive intraocular tissues during surgery. Dispersive viscoelastic devices spread out more evenly inside the eye, providing a cushioning effect that safeguards the corneal endothelium and other delicate structures from damage caused by surgical instruments or energy sources like ultrasound.

What Factors Drive the Dominance of Cataract Procedures in the Ophthalmic Viscoelastic Devices Market?

The cataract segment is the dominant application in the market. This dominance is driven by the high global prevalence of cataracts, which remain one of the leading causes of visual impairment worldwide. Ophthalmic viscoelastic devices are critical in cataract procedures to maintain the anterior chamber, protect intraocular tissues, and facilitate lens implantation. The well-established clinical protocols and large patient pool undergoing cataract surgeries contribute to the segment’s substantial market share.

As per the global ophthalmic viscoelastic devices market outlook, the glaucoma segment is experiencing notable growth. This growth is attributed to rising awareness of glaucoma as a serious eye condition and advances in minimally invasive glaucoma surgeries (MIGS), which increasingly utilize viscoelastic devices for enhanced safety and effectiveness. Additionally, as the global population ages, the number of glaucoma cases is expected to rise, further driving demand for ophthalmic viscoelastic devices in this segment.

Global Ophthalmic Viscoelastic Devices Market By Product Type 2026-2033 (%)

To get detailed segments analysis, Request a Free Sample Report

Ophthalmic Viscoelastic Devices Market Regional Insights

What Drives the Ophthalmic Viscoelastic Devices Market in North America?

North America is a leading region in the ophthalmic viscoelastic devices market, driven by its advanced healthcare infrastructure and widespread adoption of innovative medical technologies. The high prevalence of eye disorders such as cataracts and glaucoma, combined with increasing awareness about vision care, fuels demand for effective surgical devices. Robust healthcare spending and supportive reimbursement policies further accelerate market growth. The presence of major medical device manufacturers and extensive clinical research also contribute to the strong position of this region.

Ophthalmic Viscoelastic Devices Market in United States

The United States stands as the largest market within North America due to its vast patient base requiring ophthalmic surgeries. Advanced healthcare facilities, high standards of medical care, and strong investments in R&D lead to early adoption of cutting-edge viscoelastic devices. Additionally, favorable insurance coverage and government programs aimed at preventing blindness help sustain the market’s expansion.

Ophthalmic Viscoelastic Devices Market in Canada

Canada’s ophthalmic viscoelastic devices market is growing steadily, supported by a well-structured healthcare system and government initiatives promoting eye health. Increasing geriatric population and rising incidences of ocular diseases drive the need for surgical interventions using viscoelastic agents. Public awareness campaigns and improved access to specialized ophthalmic care have created favorable conditions for market growth. Canada also emphasizes stringent regulatory policies to maintain high-quality standards in medical devices.

What Is Driving the Growth of the Ophthalmic Viscoelastic Devices Market in Asia Pacific?

Asia-Pacific is witnessing rapid growth in the ophthalmic viscoelastic devices market, fueled by increasing healthcare investments, expanding medical infrastructure, and rising awareness about eye care. The region’s large and aging population contributes to a growing number of patients requiring eye surgeries. Many countries are focusing on improving healthcare accessibility and affordability, which supports the adoption of advanced surgical technologies. Collaboration between local manufacturers and global companies is also accelerating market penetration.

Ophthalmic Viscoelastic Devices Market in Japan

As per regional forecast, Japan’s ophthalmic viscoelastic devices market is characterized by a mature healthcare system and a significant elderly population, which increases demand for cataract and glaucoma treatments. The country emphasizes technological innovation and maintains strict regulatory standards for medical devices. Japan’s strong clinical research capabilities facilitate the development and adoption of advanced viscoelastic products, making it a key market in the region.

Ophthalmic Viscoelastic Devices Market in South Korea

South Korea is an emerging market benefiting from substantial investments in healthcare technology and rising awareness of eye diseases. The country’s focus on minimally invasive ophthalmic procedures and innovative device development supports the growing use of viscoelastic devices. Government healthcare policies aimed at improving surgical outcomes and patient safety further contribute to market expansion.

What Makes Europe a Significant Market for Ophthalmic Viscoelastic Devices?

As per regional outlook, Europe remains a crucial ophthalmic viscoelastic devices market due to its aging population, high incidence of eye disorders, and sophisticated healthcare systems. The region is home to several leading medical device manufacturers that drive innovation in viscoelastic formulations. Government policies supporting eye health and favorable reimbursement environments, also promote widespread adoption. Continuous research and collaboration among clinical and industrial players help Europe maintain a strong position in the global market.

Ophthalmic Viscoelastic Devices Market in Germany

Germany is a dominant country in the European market with its well-established healthcare infrastructure and high volume of ophthalmic surgeries. Strong emphasis on medical innovation and a robust medical device industry supports the adoption of the latest viscoelastic technologies. Regulatory frameworks ensure product quality and safety, enhancing physician confidence in using advanced surgical aids.

Ophthalmic Viscoelastic Devices Market in United Kingdom

As per industry analysis, the UK region benefits from increasing public awareness about eye health and a growing elderly population requiring cataract and glaucoma treatments. Government initiatives to improve access to ophthalmic care, along with reimbursement support, help drive demand for viscoelastic devices. The UK also has a thriving research environment fostering the development of innovative ophthalmic solutions.

Ophthalmic Viscoelastic Devices Market in Italy

Italy’s ophthalmic viscoelastic devices market is expanding due to an aging demographic and improved healthcare accessibility. Rising prevalence of ocular diseases and growing demand for quality surgical care underpin market growth. The country’s focus on adopting advanced medical devices and favorable reimbursement policies encourages uptake of viscoelastic products.

Global Ophthalmic Viscoelastic Devices Market By Geography, 2026-2033
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Ophthalmic Viscoelastic Devices Market Dynamics

Ophthalmic Viscoelastic Devices Market Drivers

Rising Prevalence of Eye Disorders

  • Globally, the incidence of eye-related conditions such as cataracts, glaucoma, and age-related macular degeneration is increasing, largely driven by the aging population and lifestyle factors. These diseases often necessitate surgical interventions where ophthalmic viscoelastic devices are essential to protect the eye’s delicate tissues, maintain space, and facilitate the surgical process. As the number of patients undergoing such procedures grows, so does the demand for high-quality viscoelastic devices, directly fueling market expansion.

Technological Advancements in Device Formulations

  • Recent innovations in the development of viscoelastic substances have led to the creation of diverse types such as cohesive, dispersive, and viscoadaptive materials. These advancements allow surgeons to select products that best suit specific surgical needs, enhancing the safety and effectiveness of eye surgeries. Improved formulations contribute to better control during surgery, reduce intraoperative complications, and promote faster patient recovery, which encourages greater adoption among healthcare providers.

Ophthalmic Viscoelastic Devices Market Restraints

High Cost of Advanced Devices

  • Advanced ophthalmic viscoelastic devices, especially those incorporating newer materials and enhanced biocompatibility, tend to be expensive. This high cost can be a significant barrier for hospitals and clinics in emerging markets or regions with limited healthcare budgets. Patients in low and middle-income countries may have limited access to these premium products due to affordability issues, restricting the overall market penetration in such areas.

Regulatory Challenges and Approval Delays

  • The ophthalmic viscoelastic devices market is subject to stringent regulatory standards to ensure patient safety and device efficacy. Navigating these regulatory pathways can be time-consuming and costly, delaying product launches and innovation. Prolonged approval times may deter smaller companies from entering the market and can slow the availability of cutting-edge devices to surgeons and patients.

Request Free Customization of this report to help us to meet your business objectives.

Ophthalmic Viscoelastic Devices Market Competitive Landscape

The competitive landscape of the global ophthalmic viscoelastic devices industry is marked by strategic collaborations, product innovation, and acquisitions among leading players aiming to strengthen their global presence and surgical portfolios. Major companies like Alcon, Johnson & Johnson Vision, and Bausch + Lomb continue to lead the market by leveraging strong distribution networks and introducing advanced viscoelastic formulations tailored for evolving surgical needs.

As per market strategies, in January 2024, Rayner acquired Sophi, a Swiss surgical technology firm, to expand its offerings in cataract surgery by integrating Sophi’s cutting-edge phacoemulsification systems with its intraocular lens portfolio.

Emerging startups in the ophthalmic viscoelastic devices market are focusing on innovative materials and advanced technologies to improve surgical outcomes. These new entrants are developing smart, biodegradable viscoelastic agents and leveraging AI-driven formulation methods to enhance precision, safety, and efficiency during eye surgeries. Their goal is to address unmet clinical needs while making high-quality ophthalmic care more accessible globally.

  • OcuNanoMed (Founded in 2021): OcuNanoMed is a medtech startup focused on revolutionizing viscoelastic formulations through nanotechnology and smart material science. The company develops advanced OVDs designed to dynamically respond to intraocular environments during surgery, enhancing surgical precision and patient safety. Its biodegradable and pressure-sensitive viscoelastic agents aim to minimize post-operative complications while maximizing surgical control, particularly in complex cataract and glaucoma procedures.
  • VisiBio Therapeutics (Founded in 2022): VisiBio Therapeutics concentrates on developing bioengineered ophthalmic solutions with a strong emphasis on biocompatibility and sustained intraocular protection. The startup is exploring AI-powered formulation techniques to design highly transparent, retention-optimized viscoelastic agents that can be customized based on surgical requirements. With a vision to make premium eye care more accessible, VisiBio is actively partnering with surgical centers and academic institutions across North America and Europe.

Top Player’s Company Profiles

  • Alcon (Switzerland) 
  • Bausch + Lomb (Bausch Health) (USA) 
  • Carl Zeiss Meditec AG (Germany) 
  • Johnson & Johnson Vision (USA) 
  • Rayner Intraocular Lenses Limited (UK) 
  • Bohus Biotech AB (Sweden) 
  • Lifecore Biomedical LLC (USA) 
  • Hoya Corporation (Japan) 
  • Santen Pharmaceutical Co., Ltd. (Japan) 
  • Croma-Pharma GmbH (Austria) 
  • Eyekon Medical Inc. (USA) 
  • RUMEX International Co. (USA) 
  • Ziemer Ophthalmic Systems AG (Switzerland) 
  • Ophtechnics Unlimited (India) 
  • Haohai Biological Technology (China) 
  • Amring Pharmaceutical Inc. (USA) 
  • Truviz Ophthalmic (USA) 
  • Cima Technology Inc. (USA)

Recent Developments in Ophthalmic Viscoelastic Devices Market

  • In January 2024, Rayner, a UK-based ophthalmic company, acquired Sophi, a Swiss manufacturer known for its innovative phacoemulsification systems. The acquisition aims to diversify Rayner's surgical offerings, integrating Sophi's advanced fluidics and wireless technologies to improve cataract surgery outcomes.
  • In February 2024, Nordic Group B.V. strategically acquired a company specializing in ophthalmic viscoelastic devices. This acquisition aims to enhance Nordic Group's product offerings and expand its presence in the global market. By integrating advanced viscoelastic solutions, the company seeks to address the growing demand for innovative ophthalmic surgical procedures.
  • In March 2024, Seikagaku Corporation, a pioneer in glycoscience, announced a sales alliance with Santen Pharmaceutical Co., Ltd. for the OPEGAN series of ophthalmic viscoelastic devices in Japan. This collaboration aims to strengthen the commercialization and distribution of OVDs, leveraging Santen's extensive sales network to enhance market penetration and meet the increasing demand for effective eye disease management.

Ophthalmic Viscoelastic Devices Key Market Trends

Ophthalmic Viscoelastic Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, key drivers of market growth include rising prevalence of eye disorders. The increasing number of ophthalmic surgeries across the globe is one of the key factors driving the market growth. OVDs are widely used to maintain, preserve space, displace, stabilize, and protect tissues. Key restraints in the ophthalmic viscoelastic devices market include the high cost of advanced surgical procedures, limited access to eye care in low-income regions, and stringent regulatory requirements for new product approvals. With increasing healthcare expenditure globally, particularly in emerging markets, the ophthalmic viscoelastic devices industry is anticipated to thrive. The World Bank reported an annual increase in global healthcare spending, which emphasizes the focus on enhancing healthcare systems, including eye care.

Report Metric Details
Market size value in 2024 USD 11.72 Billion
Market size value in 2033 USD 31.47 Billion
Growth Rate 11.6%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Cohesive Ophthalmic Viscoelastic and Dispersive Ophthalmic Viscoelastic
  • Application
    • Cataract ,Glaucoma ,Corneal Transplant and Vitreoretinal Surgery
  • End-user
    • Hospitals ,Ophthalmic Clinics and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Alcon (Switzerland) 
  • Bausch + Lomb (Bausch Health) (USA) 
  • Carl Zeiss Meditec AG (Germany) 
  • Johnson & Johnson Vision (USA) 
  • Rayner Intraocular Lenses Limited (UK) 
  • Bohus Biotech AB (Sweden) 
  • Lifecore Biomedical LLC (USA) 
  • Hoya Corporation (Japan) 
  • Santen Pharmaceutical Co., Ltd. (Japan) 
  • Croma-Pharma GmbH (Austria) 
  • Eyekon Medical Inc. (USA) 
  • RUMEX International Co. (USA) 
  • Ziemer Ophthalmic Systems AG (Switzerland) 
  • Ophtechnics Unlimited (India) 
  • Haohai Biological Technology (China) 
  • Amring Pharmaceutical Inc. (USA) 
  • Truviz Ophthalmic (USA) 
  • Cima Technology Inc. (USA)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Ophthalmic Viscoelastic Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Ophthalmic Viscoelastic Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Ophthalmic Viscoelastic Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Ophthalmic Viscoelastic Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Ophthalmic Viscoelastic Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Ophthalmic Viscoelastic Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

Ophthalmic Viscoelastic Devices Market Report Snapshots

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 11.72 Billion in 2024 and is poised to grow from USD 13.08 Billion in 2025 to USD 31.47 Billion by 2033, growing at a CAGR of 11.6% during the forecast period (2026–2033).

The competitive landscape of the global ophthalmic viscoelastic devices industry is marked by strategic collaborations, product innovation, and acquisitions among leading players aiming to strengthen their global presence and surgical portfolios. Major companies like Alcon, Johnson & Johnson Vision, and Bausch + Lomb continue to lead the market by leveraging strong distribution networks and introducing advanced viscoelastic formulations tailored for evolving surgical needs. 'Alcon (Switzerland) ', 'Bausch + Lomb (Bausch Health) (USA) ', 'Carl Zeiss Meditec AG (Germany) ', 'Johnson & Johnson Vision (USA) ', 'Rayner Intraocular Lenses Limited (UK) ', 'Bohus Biotech AB (Sweden) ', 'Lifecore Biomedical LLC (USA) ', 'Hoya Corporation (Japan) ', 'Santen Pharmaceutical Co., Ltd. (Japan) ', 'Croma-Pharma GmbH (Austria) ', 'Eyekon Medical Inc. (USA) ', 'RUMEX International Co. (USA) ', 'Ziemer Ophthalmic Systems AG (Switzerland) ', 'Ophtechnics Unlimited (India) ', 'Haohai Biological Technology (China) ', 'Amring Pharmaceutical Inc. (USA) ', 'Truviz Ophthalmic (USA) ', 'Cima Technology Inc. (USA)'

Globally, the incidence of eye-related conditions such as cataracts, glaucoma, and age-related macular degeneration is increasing, largely driven by the aging population and lifestyle factors. These diseases often necessitate surgical interventions where ophthalmic viscoelastic devices are essential to protect the eye’s delicate tissues, maintain space, and facilitate the surgical process. As the number of patients undergoing such procedures grows, so does the demand for high-quality viscoelastic devices, directly fueling market expansion.

Integration of AI and Digital Technologies: Artificial intelligence is increasingly being integrated into ophthalmic surgery workflows, enhancing preoperative planning, intraoperative guidance, and postoperative care. AI-driven imaging and surgical assistance allow for more precise application of viscoelastic devices, minimizing risks and improving surgical outcomes. This technological synergy is leading to higher adoption rates of viscoelastic devices compatible with these advanced systems.

North America is a leading region in the ophthalmic viscoelastic devices market, driven by its advanced healthcare infrastructure and widespread adoption of innovative medical technologies. The high prevalence of eye disorders such as cataracts and glaucoma, combined with increasing awareness about vision care, fuels demand for effective surgical devices. Robust healthcare spending and supportive reimbursement policies further accelerate market growth. The presence of major medical device manufacturers and extensive clinical research also contribute to the strong position of this region.
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients